Mqs Management LLC Novartis Ag Transaction History

Mqs Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $359,079 - $416,488	-3,879 Reduced 50.7%	3,772 $401,000
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $728,910 - $829,903	7,651 New	7,651 $740,000
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $22,233 - $26,003	-298 Reduced 3.22%	8,966 $682,000
Q2 2022 Aug 05, 2022	BUY	$80.52 - $93.75 $263,703 - $307,031	3,275 Added 54.68%	9,264 $783,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $479,778 - $542,723	5,989 New	5,989 $526,000

1,446

130M

1.12M

1.61M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.